Divi's Q4 net up 17% at Rs 231 cr

Total income for the company grew 9% at Rs 832 cr

 

Hyderabad-based active pharmaceutical ingredients(APIs) and intermediates maker, Divi's Laboratories Limited, has reported a 17.84 per cent increase in consolidated net profit at Rs 231.47 crore for the quarter ended March, 2015 as compared with Rs 196.43 crore in the corresponding quarter last year.

Total income for the company grew 9.56 per cent at Rs 832.19 crore in the quarter under review as compared with Rs 759.59 crore in the year ago period. The percentage of increase in expenditure was lower that of the total income, adding to the gross profit margins of the company during the quarter.

For the full year, the net profit of the company stood at Rs 851.52 crore, an increase of 10.11 per cent over Rs 773.34 crore in the last fiscal. The board of directors of the company has recommended a dividend of Rs 20 per equity share of Rs 2 each.